A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...

Mingze Yin et al, published in Health Data Science.3D structures of edited antibodies and corresponding antigens. Credit: Mingze Yin et al, published in Health Data Science. Researchers from Zhejiang ...

Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 ...

Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform.

From model to molecule: Partnership combines pioneering AI for protein design with genomics expertise to accelerate development of next generation enzymes Integrated DNA Technologies and Profluent Bio ...

AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

A research team maps the key tasks that define modern enzyme engineering—function annotation, structure modeling, and property prediction—and explain how AI methods now accelerate each step, from ...

Two projects at the University of California, Davis, that use artificial intelligence to design and engineer proteins for industrial and health applications have been funded by the U.S. National ...

With the advent of AI-powered protein design tools, protein-based therapeutics may no longer be constrained by the limits imposed by natural selection. Protein-based therapeutics have been ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...